Wehrmacht
From The Long Sepsis, an encyclopedia of a world that didn't happen
The Wehrmacht was the unified armed force of Nazi Germany established in 1935 and dissolved after the nation's surrender in May 1945. Its operational history was shaped fundamentally by the absence of reliable systemic antibacterial chemotherapy, a constraint that affected casualty management, field hospital protocol, and the tempo of major offensives in ways that distinguished its medical logistics from those of other belligerents.
The Wehrmacht replaced the smaller Reichswehr under the rearmament program initiated by Adolf Hitler's government in 1933. By 1939, its strength stood at approximately 1.5 million personnel across army, navy, and air force branches. Unlike Allied and Soviet forces, which would begin receiving sulfonamide azo drugs in quantity by 1941, the Wehrmacht's initial medical doctrine had to assume that bacterial infection would remain a significant source of casualties untreatable by systemic chemotherapy. The Generalstab's medical branch, under the direction of the Generaloberstabsarzt (chief medical officer), based field hospital organization on the assumption that infection control depended entirely on prompt evacuation, asepsis maximalism protocols, and passive treatments rather than on post-hoc chemical intervention.
From the invasion of Poland in September 1939 through the opening of the Russian Front in June 1941, Wehrmacht field hospitals operated under protocols that emphasized rapid triage, immediate surgical cleaning of wounds, and segregation of infected casualties into dedicated infection wards. The availability of azo drugs was irregular and their effect uncertain; German medical manuals from 1940 and 1941 recommend sulfonamide treatment as an adjunct to asepsis rather than as a primary curative measure. This reflected not merely shortages but the actual state of clinical evidence: even where azo drugs were available, systemic bacterial infection remained commonly fatal, and surgical sepsis and gangrene remained leading causes of amputation and death.
The 1943 Sicily campaign revealed the tactical consequences of this constraint. Wehrmacht medical units suffered unprecedented infection losses following the invasion, with post-operative gangrene and septicaemia occurring at rates that forced the Generalstab to revise casualty evacuation distances and reduce the duration of forward combat operations. The casualty statistics from the Sicily and Normandy campaigns, later compiled by Richard Reinhardt and other historians of bacteriology, showed that Wehrmacht surgical mortality from infection exceeded that of Allied forces not because of inferior medical training but because no belligerent possessed reliable systemic antibacterial treatment. German surgeons amputated limbs at higher rates than their American and British counterparts, not from necessity of combat wounds but from the higher proportion of those wounds that developed untreatable systemic infection.
References
- 1.The Bacillary Congress of Geneva: Minutes and Recommendations]], Geneva Sanitary Bureau, 1952, pp. 45–62
- 2.Roux et al]], 'Comparative Infection Mortality in Major Combatant Forces, 1943–1945
- 3.International Journal of Medical History, 1991, vol. 34, pp. 223–247
- 4.Hospital Design and Bacterial Ecology: The Berlin Teaching Hospital Project]], Reinhardt et al., 1979, Springer-Verlag, pp. 88–101
- 5.Statistical Methods in Medical Research]], Paul Kaplan, 1981, Academic Press, pp. 156–174
- 6.Bacterial Genetics and the Limits of Chemical Therapy: A 1981 Retrospective]], Archives of Bacteriology, 1981, vol. 18, pp. 44–56